Echo Therapeutics Inc Watch

from 8-K 28 pages 4,025,000 Shares of Common Stock Echo Therapeutics, Inc. Underwriting Agreement

from 8-K 29 pages 300,000 Shares of Common Stock Echo Therapeutics, Inc. Underwriting Agreement

from 8-K 28 pages 13,333,333 Shares of Common Stock Echo Therapeutics, Inc. Underwriting Agreement

from 8-K 29 pages 3,200,000 Shares of Common Stock Echo Therapeutics, Inc. Underwriting Agreement

from NT 10-K 1 page <page> [Schecter Dokken Kanter Logo] March 29, 2001 Mr. Jack Kohler Choicetel Communications, Inc. 9724 10th Avenue North Plymouth, Mn 55441 Dear Jack: In Connection With the Form 12b-25 That You Intend to File With the SEC, You Have Asked US to Provide a Detailed Explanation of Why Our Certification Could Not Be Completed by March 30, 2001. We Have Been Unable to Complete Our Audit of Choicetel Communications, Inc. & Subsidiary Because of Our Inability to Complete the Audit of Advants, Inc. That Company Is Resolving Issues Related to the Accounting Treatment of Certain Transactions and of Potential Asset Impairment. Research by Advants Into These Items Has Delayed Completion of the Audit. Sincerely, Schechter Dokken Kanter Andrews & Selcer, Ltd /S/ Charles Secer Charles Selcer, Cpa Shareholder Cs:klv

from SB-2/A ~50 pages Exhibit 1.1 -- Underwriting Agreement

from SB-2 ~5 pages Underwriting agreement

from SB-2 ~50 pages Underwriting agreement